Argenx Se ARGX
NASDAQ ARGX
$1,038.85 -14.61 (-1.39%)
As of: Sep 4, 2026 · 10:51 AM EDT

Argenx Se (ARGX) Cost of Revenue (2022 - 2026)

Argenx Se's (ARGX) quarterly Cost of Revenue came in at $145.0 million in Q2 2026, up 30.93% YoY from $110.7 million in Q2 2025, and up 19.83% on a QoQ basis from $121.0 million in Q1 2026.

Analysis

Argenx Se (ARGX) Cost of Revenue (2022 - 2026) Analysis & Trends

Argenx Se (ARGX) has 5 years of Cost of Revenue data on file, last reported at $145.0 million in Q2 2026.

  • Quarterly Cost of Revenue rose 30.93% year-over-year to $145.0 million in Q2 2026, while the trailing twelve-month figure through Jun 2026 was $525.1 million (up 62.33% YoY) and the FY2025 annual result came in at $450.7 million, up 98.28% from the prior year.
  • Cost of Revenue climbed to $145.0 million in Q2 2026, from $121.0 million in the prior quarter.
  • In the past five years, Cost of Revenue ranged from a high of $149.7 million in Q4 2025 to a low of $1.4 million in Q1 2022.
  • A 5-year average of $60.6 million and a median of $47.8 million in 2024 frame the typical range for Cost of Revenue.
  • Annual changes were most pronounced in 2023 — Cost of Revenue jumped 1236.37% — and 2026, when it soared 30.93%.
  • Tracing ARGX's Cost of Revenue over 5 years: stood at $12.8 million in 2022, then surged by 208.75% to $39.5 million in 2023, then jumped by 84.05% to $72.7 million in 2024, then soared by 106.02% to $149.7 million in 2025, then declined by 3.13% to $145.0 million in 2026.
  • The last three Cost of Revenue figures came in at $145.0 million (Q2 2026), $121.0 million (Q1 2026), and $149.7 million (Q4 2025), per Business Quant data.
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Cost of Rev (Qtr)
1 Vertex Pharmaceuticals 139.68 Bn 131.82 Bn 2.84 Bn 489.20 Mn
2 Regeneron Pharmaceuticals 85.68 Bn 77.68 Bn 3.93 Bn 360.70 Mn
3 Argenx Se 63.67 Bn 58.48 Bn 1.37 Bn 145.00 Mn
4 Moderna 57.02 Bn 51.88 Bn 52.00 Mn 93.00 Mn
5 Revolution Medicines 43.83 Bn 43.83 Bn - -
6 BeOne Medicines 39.97 Bn 34.87 Bn 1.53 Bn 174.53 Mn
7 Alnylam Pharmaceuticals 35.23 Bn 31.93 Bn 992.69 Mn 298.26 Mn
8 Royalty Pharma 28.56 Bn 27.72 Bn - -
9 Insmed 27.54 Bn 26.38 Bn 358.27 Mn 67.21 Mn
10 Incyte 25.49 Bn 20.95 Bn 1.57 Bn 104.96 Mn
Historic Data

Historic Data

Download Data
DateValue
Jun 30, 2026 145.00 Mn
Mar 31, 2026 121.00 Mn
Dec 31, 2025 149.69 Mn
Sep 30, 2025 109.43 Mn
Jun 30, 2025 110.75 Mn
Mar 31, 2025 81.00 Mn
Dec 31, 2024 72.66 Mn
Sep 30, 2024 59.07 Mn
Jun 30, 2024 52.38 Mn
Mar 31, 2024 43.18 Mn
Dec 31, 2023 39.48 Mn
Sep 30, 2023 36.00 Mn
Jun 30, 2023 24.02 Mn
Mar 31, 2023 18.34 Mn
Dec 31, 2022 12.79 Mn
Sep 30, 2022 10.26 Mn
Jun 30, 2022 5.01 Mn
Mar 31, 2022 1.37 Mn